The American Society of Colon and Rectal Surgeons recommends two years of monitoring with tumor markers and cross-sectional imaging, whereas the Chicago Consensus Working Group advises no surveillance in cases with negative margins and no perforation or extra-appendiceal mucin [19]. The gene discussed is MUC5AC; the disease is neoplasm.